Abstract
Purpose :
To evaluate whether concurrent phacoemulcification is increasing the risk for post-operative CMO in patients having vitrectomy and ILM peel for FTMH.
Methods :
Retrospective study of patients operated for FTMH having vitrectomy and peel in Southampton University Hospital from March 2010 till April 2015. Data extrapolated from Medisoft and Topcon OCT and included type of operation and pre- and post-operative OCT scans at 2 weeks and 3 months post-vitrectomy.
Results :
411 eyes from 391 patients having vitrectomy and ILM peel for FTMH were included. 318 (77.4%) eyes had concurrent Phaco-IOL. Post-operative CMO was present in total in 16 eyes (3.9%). In the combined Phaco/Vitrectomy group CMO was present in 12 eyes (3.77%), while in the vitrectomy alone group CMO was present in 4 eyes (4.34%). Statistical analysis showed that p value for the presence of CMO between the two groups was 0.802. In all cases CMO resolved with topical treatment with steroidal and non steroidal anti-inflammatory agents. There was no re-opening of macular holes associated with post-operative CMO.
Conclusions :
Our study shows that concurrent phacoemulcification in patients having vitrectomy and peel for FTMH does not seem to increase the presence of post-operative CMO and is not associated with re-opening of the macular hole. Prospective studies are required to consider adding non steroidal anti-inflammatory agents to prevent presence of post-operative CMO.
This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.